K. McColl

发表

Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats.

E. El-Omar, J. Mcgregor, K. Hillan, 1993, Gut.

Measurement of urea and ammonium concentrations in gastric juice.

K. McColl, W. Neithercut, A. E. el Nujumi, 1993, Journal of clinical pathology.

Helicobacter pylori utilises urea for amino acid synthesis.

T. Preston, C. Slater, K. McColl, 1996, FEMS immunology and medical microbiology.

A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients.

E. El-Omar, I. Penman, K. McColl, 1995, Gut.

Gastrin releasing peptide and its value in assessing gastric secretory function

E. El-Omar, K. McColl, K. E. McColl, 1995, Alimentary pharmacology & therapeutics.

Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection.

E. El-Omar, J. Mcgregor, I. Penman, 1994, Gastroenterology.

Helicobacter pylori does not release cysteamine into gastric juice.

K. McColl, D. Gillen, W. Neithercut, 1997, Journal of clinical pathology.

Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk.

E. Holme, W. Hillis, D. Birnie, 1998, European heart journal.

Effect of H. pylori infection on gastrin and gastric acid secretion

E. El-Omar, K. McColl, 1994 .

Helicobacter pylori in the faeces?

K. McColl, C. Williams, L. Weaver, 1999, QJM : monthly journal of the Association of Physicians.

Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations.

K. McColl, W. Neithercut, R. Chittajallu, 1991, Gut.

Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation.

K. McColl, W. Neithercut, J. Ardill, 1992, Scandinavian journal of gastroenterology.

Suicidal destruction of Helicobacter pylori: metabolic consequence of intracellular accumulation of ammonia.

K. McColl, M. Hossack, W. Neithercut, 1991, Journal of clinical pathology.

Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine.

E. El-Omar, I. Penman, K. McColl, 1994, Gut.

Controlled study of the effects of intravenous famotidine on intragastric pH in bleeding peptic ulcers

K. McColl, S. Mann, A. Macdonald, 1991, Alimentary Pharmacology and Therapeutics.

Gastrin levels in Pernicious anaemia

K. McColl, J. Ardill, S. Banerjee, 1994, Regulatory Peptides.

A comparison of the effects of treatment with either famotidine 40 mg or cimetidine 800 mg nocte on gastric acid secretion and serum gastrin

K. McColl, G. Crean, G. Laferla, 1988, Alimentary pharmacology & therapeutics.

Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer.

E. El-Omar, K. McColl, W. Watson, 1996, Gastroenterology.

Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic

J. Seenan, K. McColl, K. McColl, 2008, Gut.

Review article: Helicobacter pylori and gastro‐oesophageal reflux disease − the European perspective

K. McColl, K. McColl, 2004, Alimentary pharmacology & therapeutics.

Effect of low‐dose omeprazole on gastric acid secretion in duodenal ulcer patients

K. McColl, G. Mclauchlan, G. P. CREAN, 1988, Alimentary pharmacology & therapeutics.

Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium.

K. McColl, W. Neithercut, M. Hossack, 1991, Journal of clinical pathology.

Urease-mediated destruction of bacteria is specific for Helicobacter urease and results in total cellular disruption.

K. McColl, C. Williams, M. Hossack, 1994, FEMS immunology and medical microbiology.

Ammonium metabolism and protection from urease mediated destruction in Helicobacter pylori infection.

K. McColl, C. Williams, W. Neithercut, 1993, Journal of clinical pathology.

The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer.

E. El-Omar, K. McColl, D. Gillen, 1997, Seminars in gastrointestinal disease.

Effect of omeprazole and feeding on plasma gastrin in patients with achlorhydria

K. McColl, S. Banerjee, A. Beattie, 1995, Alimentary pharmacology & therapeutics.

The effect of H2‐blockade on plasma gastrin concentration in patients with an achlorhydric stomach

K. McColl, J. Ardill, G. Fullarton, 1992, Alimentary pharmacology & therapeutics.

Marked rebound acid hypersecretion after treatment with ranitidine.

E. El-Omar, I. Penman, K. McColl, 1996, The American journal of gastroenterology.

THYROID HORMONES IN SERIOUS NON-THYROIDAL ILLNESS

G. Somers, L. Vanhaelst, R. Naeije, 1976, The Lancet.

Helicobacter pylori infection and its role in human disease — an overview

K. McColl, K. McColl, 1996, Pharmacy World and Science.

Eradicating Helicobacter pylori reduces hypergastrinaemia during long term omeprazole treatment

K. Oien, K. McColl, J. Ardill, 1998 .

Antipyrine metabolism in acute hepatic porphyria in relapse and remission.

M. Brodie, M. Moore, K. McColl, 1987, British journal of clinical pharmacology.

Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects.

K. McColl, K. McColl, A. E. el Nujumi, 1991, Scandinavian journal of gastroenterology.

Helicobacter pylori: clinical aspects.

K. McColl, K. McColl, 1997, The Journal of infection.

Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection.

K. McColl, K. McColl, W. Neithercut, 1992, Gut.

Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy.

K. McColl, K. McColl, G. Fullarton, 1992, Scandinavian journal of gastroenterology.